Philips Medical Systems Recalls Azurion 3 M15 Systems Due to Unexpected Table Movement
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Philips Medical Systems is recalling 802 Azurion 3 M15 units worldwide after reports that patient tables may move unexpectedly when the Reset Geometry button is activated.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 25, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Philips Medical Systems Nederland B.V. has initiated a voluntary recall of the Azurion 3 M15 System. The recall was issued following reports that, under certain conditions, the patient table may move unexpectedly when the "Reset Geometry" button is pressed. This unintended movement can occur even if a table lock is currently active, potentially creating a hazard during medical procedures.
Which Products Are Affected
The recall involves a total of 802 units, with 45 units distributed within the United States and 757 units distributed internationally. The following models and software versions are affected:
- Product Name: Azurion 3 M15 System
- Model Numbers: 722064, 722222, 722230, and 722280 (OUS only)
- Software Versions: All versions (R1.X, R2.X, R3.X)
- UDI-DIs: 884838085282, 884838099210, 884838116733
- Serial Numbers: All serial numbers for the specified models are included in this recall.
Distribution was worldwide, including US nationwide and over 100 other countries across Europe, Asia, Africa, and the Americas.
What You Should Do
Healthcare facilities and operators using the Azurion 3 M15 System should identify if their equipment matches the model numbers and software versions listed above. As this is a firm-initiated voluntary recall, users should follow all specific instructions and safety protocols provided by Philips Medical Systems Nederland B.V. regarding the use of the Reset Geometry function.
Why This Matters
Unexpected movement of a patient table during a medical procedure poses a risk of injury to both patients and clinical staff. This Class II recall indicates that while the risk of serious adverse health consequences may be remote, the defect could cause temporary or medically reversible health issues.
Source
Information provided by the FDA. Recall Number: Z-1345-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category